Monday, December 29, 2025
Monday, December 29, 2025

Cancer-related fatigue is a debilitating yet all-too-common condition, which can severely affect quality of life for patients undergoing treatment. For those struggling with CRF, there have been no effective pharmaceutical treatments for the constellation of symptoms that together define the syndrome. Researchers found that a metabolism-targeting drug called dichloroacetate (DCA) helped alleviate CRF in mice, without interfering with cancer treatments.

A clinical trial into treatment for gestational diabetes, involving more than 500 pregnant women, has revealed what the lead academic has described as a significant step forward for women. The research has found benefits for both mothers and their newborn babies, and alleviated concerns over the use of the drug metformin, including less weight gain for mothers; no evidence of increase in preterm birth; and no differences in adverse neonatal outcomes.

More Articles …

  1. Wearable sensor to monitor 'last line of defense' antibiotic
  2. Type 2 diabetes diagnosis at age 30 can reduce life expectancy by up to 14 years
  3. Bioengineering breakthrough increases DNA detection sensitivity by 100 times
  4. Trans women may be banned from women's NHS wards
  5. Leicester: Face masks mandatory again in parts of city hospitals
  6. Mum fears her son could die waiting for life changing surgery
Page 1850 of 1938